Vigil Neuroscience (VIGL) Revenue & Revenue Breakdown
Vigil Neuroscience Revenue Highlights
00
Vigil Neuroscience Revenue by Period
Vigil Neuroscience Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | - |
Vigil Neuroscience Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.93M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | - |
Vigil Neuroscience Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TRDA | Entrada Therapeutics | $129.01M | $19.57M |
MOLN | Molecular Partners | $7.04M | $2.74M |
PRTC | PureTech Health | $3.33M | $178.57K |
OPT | Opthea | $108.41K | $61.27K |
CGEM | Cullinan Oncology | - | - |
PHVS | Pharvaris | - | - |
RLYB | Rallybio | - | $299.00K |
PMVP | PMV Pharmaceuticals | - | - |
VIGL | Vigil Neuroscience | - | - |
THRD | Third Harmonic Bio | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
CMPX | Compass Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |
PEPG | PepGen | - | - |
TYRA | Tyra Biosciences | - | - |